Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8-9
|
pubmed:dateCreated |
1987-12-15
|
pubmed:abstractText |
The clinical characteristics of psychiatric side effects of bromocriptine in patients with Parkinson's disease were studied in 12 cases. The clinical picture was characterized by hallucinations and delirium. Daily doses of bromocriptine (more than 30 mg daily), not duration of the disease or pretreatment with levodopa or previous psychiatric diseases, appeared to be the most important causal factor.
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0035-3787
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
143
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
608-11
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3671965-Aged,
pubmed-meshheading:3671965-Bromocriptine,
pubmed-meshheading:3671965-Cognition Disorders,
pubmed-meshheading:3671965-Delusions,
pubmed-meshheading:3671965-Female,
pubmed-meshheading:3671965-Hallucinations,
pubmed-meshheading:3671965-Humans,
pubmed-meshheading:3671965-Male,
pubmed-meshheading:3671965-Mental Disorders,
pubmed-meshheading:3671965-Middle Aged,
pubmed-meshheading:3671965-Parkinson Disease
|
pubmed:year |
1987
|
pubmed:articleTitle |
[Neuropsychic side effects of bromocriptine in Parkinson's disease].
|
pubmed:affiliation |
Service de Neurologie, Centre Hospitalier Universitaire Purpan, Toulouse.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|